Team management, twinning, and telemedicine in retinoblastoma: A 3‐tier approach implemented in the first eye salvage program in Jordan
- 25 February 2008
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (2) , 241-244
- https://doi.org/10.1002/pbc.21489
Abstract
Background This study evaluated the outcome of retinoblastoma patients, when employing a telemedicine‐based twinning program in Jordan. Procedure This cohort study included patients at the King Hussein Cancer Centre (KHCC; Amman, Jordan) who received consultations for retinoblastoma from March 2003 to September 2006. A collaborative program was established with the International Outreach Program at St. Jude Children's Research Hospital in Memphis, Tennessee. Cases were discussed using an Internet consultation service where fundus images, clinical history, and proposed treatment were reviewed. Selected cases were further discussed via videoconferencing and electronic mail. Results Thirty‐three children with retinoblastoma (20 bilateral) were treated at KHCC. The median age at diagnosis was 7 months for patients with bilateral retinoblastoma and 35 months for patients with unilateral retinoblastoma. Of the 20 patients with bilateral disease, 12 were newly diagnosed and 8 had received prior treatment. Our success in the bilateral cases was most evident in the previously untreated group, in which only six eyes (25%) were enucleated and four eyes (17%) were irradiated. Of the 13 patients with unilateral retinoblastoma, 12 underwent enucleation, and 6 required radiation. Neither group experienced mortality. Conclusions Twinning has positively impacted survival and ocular salvage in Jordan. By partnering a team of professionals with mentors willing to provide close supervision, the highly specialized management of retinoblastoma can be successfully implemented in a developing country. Pediatr Blood Cancer 2008;51:241–244.Keywords
Funding Information
- Research to Prevent Blindness, Inc.
- St. Giles Foundation
This publication has 8 references indexed in Scilit:
- Effect on Ocular Survival of Adding Early Intensive Focal Treatments to a Two-Drug Chemotherapy Regimen in Patients With RetinoblastomaAmerican Journal of Ophthalmology, 2005
- Current Management of RetinoblastomaRetina, 2004
- Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing countryPediatric Blood & Cancer, 2004
- Practical Approach to Management of RetinoblastomaArchives of Ophthalmology (1950), 2004
- Treatment of Intraocular Retinoblastoma With Vincristine and CarboplatinJournal of Clinical Oncology, 2003
- Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation1Published by Elsevier ,2002
- Chemoreduction and Local Ophthalmic Therapy for Intraocular RetinoblastomaJournal of Clinical Oncology, 2000
- Recent Developments in the Management of RetinoblastomaJournal of Pediatric Ophthalmology & Strabismus, 1999